THE EFFECT OF DEXAMETHASONE ON THE EXCRETION OF OESTRIOL AND FOLLICLE-STIMULATING HORMONE IN PATIENTS WITH STEIN—LEVENTHAL SYNDROME

in Journal of Endocrinology
Authors:
W. R. BUTT
Search for other papers by W. R. BUTT in
Current site
Google Scholar
PubMed
Close
,
A. C. CROOKE
Search for other papers by A. C. CROOKE in
Current site
Google Scholar
PubMed
Close
,
F. J. CUNNINGHAM
Search for other papers by F. J. CUNNINGHAM in
Current site
Google Scholar
PubMed
Close
, and
R. PALMER
Search for other papers by R. PALMER in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

When patients with the Stein—Leventhal syndrome are treated with dexamethasone they show an increase in the excretion of oestriol (Crooke, Butt, Palmer, Morris, Edwards, Taylor & Short, 1963). It was suggested that this might be the result of an increase in the secretion of gonadotrophin since, working in this laboratory, P. S. Brown (1956) had shown that the excretion of follicle-stimulating hormone (FSH) may rise when patients are treated with cortisone.

In the present investigation eight patients with Stein—Leventhal syndrome were given dexamethasone 3 mg. daily for 5 days and their urine was collected in 24 hr. lots for 2 days before and for 6 days after starting treatment. The specimens were then

article image
pooled in 2-day lots and analysed for oestriol by the method of J. B. Brown (1955) and for FSH by the ovarian augmentation method of P. S. Brown (1955). The excretion of oestriol was expressed as μg./24hr.

 

  • Collapse
  • Expand